D’Amico, R.; Fusco, R.; Siracusa, R.; Impellizzeri, D.; Peritore, A.F.; Gugliandolo, E.; Interdonato, L.; Sforza, A.M.; Crupi, R.; Cuzzocrea, S.;
et al. Inhibition of P2X7 Purinergic Receptor Ameliorates Fibromyalgia Syndrome by Suppressing NLRP3 Pathway. Int. J. Mol. Sci. 2021, 22, 6471.
https://doi.org/10.3390/ijms22126471
AMA Style
D’Amico R, Fusco R, Siracusa R, Impellizzeri D, Peritore AF, Gugliandolo E, Interdonato L, Sforza AM, Crupi R, Cuzzocrea S,
et al. Inhibition of P2X7 Purinergic Receptor Ameliorates Fibromyalgia Syndrome by Suppressing NLRP3 Pathway. International Journal of Molecular Sciences. 2021; 22(12):6471.
https://doi.org/10.3390/ijms22126471
Chicago/Turabian Style
D’Amico, Ramona, Roberta Fusco, Rosalba Siracusa, Daniela Impellizzeri, Alessio Filippo Peritore, Enrico Gugliandolo, Livia Interdonato, Andrea Maria Sforza, Rosalia Crupi, Salvatore Cuzzocrea,
and et al. 2021. "Inhibition of P2X7 Purinergic Receptor Ameliorates Fibromyalgia Syndrome by Suppressing NLRP3 Pathway" International Journal of Molecular Sciences 22, no. 12: 6471.
https://doi.org/10.3390/ijms22126471
APA Style
D’Amico, R., Fusco, R., Siracusa, R., Impellizzeri, D., Peritore, A. F., Gugliandolo, E., Interdonato, L., Sforza, A. M., Crupi, R., Cuzzocrea, S., Genovese, T., Cordaro, M., & Di Paola, R.
(2021). Inhibition of P2X7 Purinergic Receptor Ameliorates Fibromyalgia Syndrome by Suppressing NLRP3 Pathway. International Journal of Molecular Sciences, 22(12), 6471.
https://doi.org/10.3390/ijms22126471
